133 results on '"Cañas CA"'
Search Results
2. Sobre Las Autoras
- Author
-
Ovalle Pinzón, Nicol Valentina, Yate Martínez, Alejandra, Lozano Penagos, Mayra Katherine, Cuéllar Contreras, Ángela del Pilar, and Cañas Cañas, Luz Helena
- Published
- 2023
3. Créditos
- Author
-
Ovalle Pinzón, Nicol Valentina, Yate Martínez, Alejandra, Lozano Penagos, Mayra Katherine, Cuéllar Contreras, Ángela del Pilar, and Cañas Cañas, Luz Helena
- Published
- 2023
4. Introducción
- Author
-
Ovalle Pinzón, Nicol Valentina, Yate Martínez, Alejandra, Lozano Penagos, Mayra Katherine, Cuéllar Contreras, Ángela del Pilar, and Cañas Cañas, Luz Helena
- Published
- 2023
5. 2. Educación Inclusiva y Ruralidad en Colombia: Creencias de Una Muestra de Maestros Colombianos
- Author
-
Ovalle Pinzón, Nicol Valentina, Yate Martínez, Alejandra, Lozano Penagos, Mayra Katherine, Cuéllar Contreras, Ángela del Pilar, and Cañas Cañas, Luz Helena
- Published
- 2023
6. Agradecimientos
- Author
-
Ovalle Pinzón, Nicol Valentina, Yate Martínez, Alejandra, Lozano Penagos, Mayra Katherine, Cuéllar Contreras, Ángela del Pilar, and Cañas Cañas, Luz Helena
- Published
- 2023
7. 1. Educación Inclusiva y Creencias Del Profesorado. Recorriendo El Camino para Desandar Iimaginario.
- Author
-
Ovalle Pinzón, Nicol Valentina, Yate Martínez, Alejandra, Lozano Penagos, Mayra Katherine, Cuéllar Contreras, Ángela del Pilar, and Cañas Cañas, Luz Helena
- Published
- 2023
8. 3. Educación Inclusiva para Niños y Niñas Con Trastorno del Espectro del Autismo (TEA): Creencias de Maestras de Educación Inicial
- Author
-
Ovalle Pinzón, Nicol Valentina, Yate Martínez, Alejandra, Lozano Penagos, Mayra Katherine, Cuéllar Contreras, Ángela del Pilar, and Cañas Cañas, Luz Helena
- Published
- 2023
9. Referencias
- Author
-
Ovalle Pinzón, Nicol Valentina, Yate Martínez, Alejandra, Lozano Penagos, Mayra Katherine, Cuéllar Contreras, Ángela del Pilar, and Cañas Cañas, Luz Helena
- Published
- 2023
10. 5. Educación Inclusiva Desde la Visión de las Familias: Las Creencias de Padres y Madres de Niños y Niñas Con y Sin Discapacidad
- Author
-
Ovalle Pinzón, Nicol Valentina, Yate Martínez, Alejandra, Lozano Penagos, Mayra Katherine, Cuéllar Contreras, Ángela del Pilar, and Cañas Cañas, Luz Helena
- Published
- 2023
11. Epílogo
- Author
-
Ovalle Pinzón, Nicol Valentina, Yate Martínez, Alejandra, Lozano Penagos, Mayra Katherine, Cuéllar Contreras, Ángela del Pilar, and Cañas Cañas, Luz Helena
- Published
- 2023
12. 4. Educación Inclusiva y Discapacidad: ¿Dónde Están Las Oportunidades para Jóvenes con Discapacidad Intelectual en la Educación Superior Colombiana? Creencias de Maestros Universitarios
- Author
-
Ovalle Pinzón, Nicol Valentina, Yate Martínez, Alejandra, Lozano Penagos, Mayra Katherine, Cuéllar Contreras, Ángela del Pilar, and Cañas Cañas, Luz Helena
- Published
- 2023
13. Psychiatric manifestations in patients with dysautonomy associated with systemic lupus erythematosus
- Author
-
Cañas, CA, primary, Rincón-Hoyos, HG, additional, Izquierdo, JH, additional, Bonilla-Abadía, F, additional, and Arbeláez-Cortés, A, additional
- Published
- 2012
- Full Text
- View/download PDF
14. Biochemical comparison of venoms from young Colombian Crotalus durissus cumanensis and their parents
- Author
-
Céspedes, N, primary, Castro, F, additional, Jiménez, E, additional, Montealegre, L, additional, Castellanos, A, additional, Cañas, CA, additional, Arévalo-Herrera, M, additional, and Herrera, S, additional
- Published
- 2010
- Full Text
- View/download PDF
15. A rare association of localized scleroderma type morphea, vitiligo, autoimmune hypothyroidism, pneumonitis, autoimmune thrombocytopenic purpura and central nervous system vasculitis. Case report
- Author
-
Bonilla-Abadía Fabio, Muñoz-Buitrón Evelyn, Ochoa Carlos D, Carrascal Edwin, and Cañas Carlos A
- Subjects
Localized scleroderma ,Morphea ,Multiple autoimmune syndrome ,Central nervous system vasculitis ,Medicine ,Biology (General) ,QH301-705.5 ,Science (General) ,Q1-390 - Abstract
Abstract Background The localized scleroderma (LS) known as morphea, presents a variety of clinical manifestations that can include systemic involvement. Current classification schemes divide morphea into categories based solely on cutaneous morphology, without reference to systemic disease or autoimmune phenomena. This classification is likely incomplete. Autoimmune phenomena such as vitiligo and Hashimoto thyroiditis associated with LS have been reported in some cases suggesting an autoimmune basis. To our knowledge this is the first case of a morphea forming part of a multiple autoimmune syndrome (MAS) and presenting simultaneously with autoimmune thrombocytopenic purpura and central nervous system vasculitis. Case presentation We report an uncommon case of a white 53 year old female patient with LS as part of a multiple autoimmune syndrome associated with pneumonitis, autoimmune thrombocytopenic purpura and central nervous system vasculitis presenting a favorable response with thrombopoietin receptor agonists, pulses of methylprednisolone and cyclophosphamide. Conclusion Is likely that LS have an autoimmune origin and in this case becomes part of MAS, which consist on the presence of three or more well-defined autoimmune diseases in a single patient.
- Published
- 2012
- Full Text
- View/download PDF
16. Erythema nodosum as first clinical manifestation of metastatic neuroendocrine tumor: A case report.
- Author
-
Barona-Rommy D, Bravo JC, Varela MJ, Arango LG, and Cañas CA
- Abstract
Erythema nodosum (EN) is a reactive inflammatory panniculitis, which has been associated with medications, infections, autoimmune and autoinflammatory diseases. It has rarely been associated with neoplasms. We present the case of a 61-year old woman who was admitted because 3-week history of painful erythematous subcutaneous nodules on the lower limbs clinically consistent with EN, which was confirmed by skin biopsy. The patient denied use of medication. No general or systemic symptoms were present. As part of his study, an abdominal ultrasound and later magnetic resonance imaging (MRI) was done and lesions suggestive of liver metastases were reported. An ultrasound guided liver biopsy was then performed and pathology studies evidence a well differentiated grade II gastro-enteropancreatic neuroendocrine tumor (GEP-NET). A 9mTc-Octreotide scintigraphy evidenced a positive expression of somatostatin receptor in the liver and in a nodular mesenteric lesion in contact with an intestinal loop. The patient began treatment with lanreotide and was scheduled for cytoreductive surgery. During surgery, 50 cm of the small intestine, gallbladder, mesenteric fat and a 4.2x3.3 × 1 cm tumor located on the VII hepatic lobe were resected. Subsequently EN lesions of the lower extremities resolved. We present a rare case of GEP-NET-associated EN, that improved with surgical tumor cytoreduction and hormone therapy., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
17. Is the acute compartment syndrome diagnosed in snake bites true?: A review.
- Author
-
Cañas CA
- Subjects
- Humans, Animals, Antivenins therapeutic use, Acute Disease, Snake Bites complications, Snake Bites therapy, Snake Bites diagnosis, Compartment Syndromes etiology, Compartment Syndromes diagnosis, Compartment Syndromes therapy
- Abstract
Envenomation caused by venomous snakes can induce clinical symptoms and signs resembling those of traumatic acute compartment syndrome (ACS), but it is uncertain whether its treatment guidelines are applicable or beneficial for ACS that is associated to snakebites. Nonetheless, recommendations for the diagnosis and treatment of trauma-induced ACS, particularly following fractures of the tibial diaphysis, are extrapolated to the diagnosis and treatment of snakebites despite evidence that the ensuing injuries are frequently not true ACS. Most biologists agree that the venom of snakes, especially those of the Crotalinae family (vipers) evolved to immobilize, kill, and initiate the digestion of their prey. The human local effects of viper envenoming are the result of digestion like those described in biological processes as acute pancreatitis, including secondary inflammatory and induction of reparative effects. The first-line treatment should focus on mitigation of venom-induced tissue digestion rather than surgery solution for "ACS-like" symptoms and signs. This type of analysis leads to questioning that treatment of ACS associated with snakebite cannot be extrapolated from recommendations formulated for trauma-induced ACS. The cornerstone of snake envenoming treatment is antivenom, and some clinical and experimental experiences start to show that surgical procedures frequently employed for trauma-induced ACS, such as debridement and fasciotomy, may be exaggerated and even deleterious in most viper bite envenoming., Competing Interests: The author have no funding and conflicts of interest to disclose., (Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
18. Bronchiectasis, lymphadenopathies related to BAFF overexpression and lymphoplasmacytic cystitis as adverse events associated with prolonged use of rituximab in systemic autoimmune rheumatic diseases.
- Author
-
Cañas CA, Posso-Osorio I, Pérez-Uribe V, and Erazo-Martínez V
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Antirheumatic Agents adverse effects, Antirheumatic Agents administration & dosage, Lymphadenopathy chemically induced, Retrospective Studies, Autoimmune Diseases chemically induced, Autoimmune Diseases drug therapy, B-Cell Activating Factor, Bronchiectasis drug therapy, Cystitis chemically induced, Rheumatic Diseases drug therapy, Rituximab adverse effects, Rituximab administration & dosage
- Abstract
Background: The long-term use of rituximab (RTX) has been gaining ground in the treatment of systemic autoimmune diseases. The adverse events (AEs) associated with its use different to infections are being reported., Methods: A cohort of patients with SAIDs treated at a high-complexity center in Cali (southwestern Colombia) with follow-up from January 2008 to December 2022 were examined to search for potential AEs associated with prolonged use of RTX., Results: From 178 patients with long-term use of RTX 3 (1.68%) had lymphadenopathies with lymphoid follicular hyperplasia related to BAFF overexpression, 4 (2.24%) with bronchiectasis, and 4 (2.24%) with lymphoplasmacytic cystitis., Conclusion: Bronchiectasis, lymphoid follicular hyperplasia related to BAFF overexpression, and lymphoplasmacytic cystitis may be life-threatening long-term AEs in patients with prolonged use of RTX., (Copyright © 2024 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
19. Biological changes in human B-cell line Ramos (RA.1) related to increasing doses of human parathyroid hormone.
- Author
-
Rios-Serna LJ, Rosero AM, Tobón GJ, and Cañas CA
- Abstract
Background: The etiopathogenesis of autoimmune diseases is multifactorial, including hormonal factors. Remission of autoimmunity has been observed following treatment for concomitant hyperparathyroidism. Additionally, patients with autoimmune diseases have shown increased expression of parathyroid hormone receptor (PTH1R) and altered distribution of B cells subsets. Hence, this study aims to evaluate potential mechanisms and in vitro effects of PTH stimulation on B lymphocytes., Methods: Using the human B-cell line Ramos (RA.1), various biological effects were evaluated with and without parathyroid hormone (PTH) stimulation at varying concentrations. Flow cytometry was employed to evaluate the phenotype of B lymphocytes based on IgD and CD38 expression, apoptosis induction via Annexin V and proliferation using CFSE. IgM production was quantified through ELISA, and Western blot analysis was performed to assess syk protein phosphorylation as an indicator of cell activation., Results: Ramos cells (RA.1) evidenced a statistically significant change in the phenotype under human PTH stimulation, demonstrating an increased proportion of germinal centre cells (Bm3-Bm4) when stimulated with high concentrations of PTH., Conclusions: The in vitro effects of PTH in B cells subsets align with previous findings of an altered phenotype in B lymphocytes expressing PTH1R among autoimmune disease patients, suggesting a potential role of this hormone in the pathophysiology of autoimmune diseases. However, further studies are necessary to elucidate the mechanisms by which PTH generates observed effects in B lymphocytes and to determine if PTH plays a role in autoimmunity., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
20. Envenomation by Eyelash Viper Bothriechis schlegelii (Berthold, 1846) in Southwestern Colombia.
- Author
-
Cañas CA, Erazo-Martinez V, Pérez-Uribe V, Castaño-Valencia S, and Castro-Herrera F
- Subjects
- Animals, Humans, Young Adult, Adult, Colombia epidemiology, Antivenins therapeutic use, Pain drug therapy, Pain etiology, Edema etiology, Afibrinogenemia, Crotalinae, Bothrops
- Abstract
Introduction: Bothriechis schlegelii is a Crotaline viperid species of Central America and Northern South America. The characteristics of its envenomation have not been well established. We present clinical characteristics of human cases evaluated and treated in a hospital in southwestern Colombia., Methods: We evaluated data from patients who suffered Bothriechis schlegelii envenomation and were seen at Fundación Valle del Lili Hospital, Cali, Colombia between 2011 and 2022., Results: Eight patients were included, with a median age of 24 years. Snakebites occurred in rural areas. Six (75%) patients were bitten on the upper extremities in relation to the arboreal habits of this animal. The most common symptoms were pain and edema ( N = 8, 100%), ecchymoses ( N = 2, 25%), and paresthesia ( N = 2, 25%). The most common systemic findings were hypofibrinogenemia ( N = 8, 100%) and prolonged prothrombin time in five patients ( N = 5, 62.5%). All were treated with polyvalent antivenom for Colombian snakes, with a good response and outcome., Conclusions: Most bite sites from B. schlegelii were on the upper limbs. All patients had both local manifestations, including edema, pain, and systemic effects with hypofibrinogenemia, but none had systemic bleeding. Every patient received antivenom and had favorable outcomes.
- Published
- 2024
- Full Text
- View/download PDF
21. Viperidae snake envenomation from a highly complex hospital in southwestern Colombia.
- Author
-
Erazo-Martínez V, Posso-Osorio I, Ruiz-Ordoñez I, Castro-Herrera F, Castaño-Valencia S, Delgado-Mora T, and Cañas CA
- Abstract
Background: Snake envenomation is a medical condition with high morbidity and mortality in southwestern Colombia., Objectives: To describe the characteristics of the envenomation caused by Viperidae snakes view in a highly complex hospital in Southwestern Colombia., Methods: A cross-sectional study was carried out. Patients treated for Viperidae snake envenomation from 2001 to 2020 in a Hospital Fundación Valle del Lili, Cali, Colombia, were studied., Results: Twenty-eight patients were included. Envenomation was caused by the genera Bothrops , Bothriechis , Porthidium, and Bothrocophias . The median age was 37.7 (±20.6), and they were predominantly male (19, 68%). Bites occurred on the upper extremities in 16 (57%) patients. Pain (23, 81%) and edema (22, 78%) were the most common clinical symptoms. Thirteen (46%) patients presented coagulopathy. Prolonged prothrombin and activated partial thromboplastin times were common: (22, 78% and 15, 53%, respectively). Twenty (71%) patients were treated with polyvalent antivenom (median dose of 6 (2-15) vials). The median time between the accident and antivenom administration was 9 h (5.5-17). Door-to-needle time was 37.5 (0-62) min. Eighteen (64%) patients were admitted to the intensive care unit. Three (11%) patients had serum sickness. Seven (25%) developed infectious complications, four (14%) had surgery, one (3%) had compartment syndrome, one (3%) underwent amputation of the affected limb, and one (3%) patient died., Conclusions: Local manifestations and coagulopathy were common clinical features. Polyvalent antivenom was an effective treatment for disease control. Significant complications were associated with delays in seeking medical care., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
22. Severe cerebral edema related to oral methadone: A case report and literature review.
- Author
-
Cañas CA, Posso-Osorio I, Rivera-Londoño R, Bolaños JD, and Granados AM
- Abstract
Introduction: Opioids are widely used for pain management, and increased intracranial pressure (ICP) has been evidenced in some cases. We reported a patient with severe cerebral edema after initiating methadone and its complete resolution upon discontinuing the medication. Additionally, a review of the literature is made., Case Report: A 53-year-old woman patient with a history of systemic lupus erythematosus developed mechanic chronic lower back pain, refractory to conventional treatments. She presented improvement with oxycodone. She withdrew this medication due to a lack of supplies in her country (Colombia) and showed withdrawal symptoms. She consulted the emergency department, where oral methadone was started and symptom control was achieved. Three days after admission, she presented intense headaches and emesis. A brain CT scan was performed in which severe cerebral edema was appreciated. Methadone was discontinued, and neurological symptoms quickly disappeared. A follow-up brain CT scan was performed later, finding full resolution of the edema., Conclusion: A case of severe cerebral edema associated with the initiation of oral methadone and its rapid resolution without neurological sequelae after its withdrawal is presented, clinicians must be attentive to this adverse event., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
23. Antiestrogen agents could be associated with a form of polyarticular osteoarthritis.
- Author
-
Cañas CA, Varela MJ, Posso-Osorio I, Esquivel JD, Nieto-Aristizábal I, Rivera-Londoño R, Bolaños JD, and Bonilla-Abadía F
- Subjects
- Humans, Estrogen Receptor Modulators, Osteoarthritis
- Published
- 2024
- Full Text
- View/download PDF
24. Relapsing-Remitting Form of Arthropathy Occurs in Patients With Mast Cell Activation Syndrome.
- Author
-
Cañas CA, Tobón GJ, Bonilla-Abadía F, and Posso-Osorio I
- Subjects
- Humans, Disease Progression, Mast Cell Activation Syndrome, Joint Diseases, Multiple Sclerosis, Relapsing-Remitting
- Abstract
Competing Interests: The authors declare no conflict of interest.
- Published
- 2024
- Full Text
- View/download PDF
25. Idiopathic gigantomastia exacerbated during pregnancy. Its relationship with autoimmunity: A case report.
- Author
-
Biancha-Vasco JM, Muñoz P AL, Gómez J, Rios-Serna LJ, Ruiz-Ordoñez I, Tobón GJ, Sua LF, Sánchez A, and Cañas CA
- Subjects
- Female, Pregnancy, Humans, Adult, Breast pathology, Hypertrophy pathology, Autoimmunity, Hashimoto Disease
- Abstract
Gigantomastia is a rare entity characterized by diffuse and excessive breast enlargement. It mainly occurs during puberty and pregnancy as a consequence of hormonal fluctuations. We report an unusual case of gigantomastia in a 29-year-old woman with a history of personal and familiar autoimmune phenomena. She had autoimmune thyroiditis and several positive autoantibodies, and developed 3 crises of the disease, 1 related to pregnancy (possibly hormone-mediated), and 2 unrelated to pregnancy in which an autoimmune role is raised based in clinical, histological and laboratory findings. Immunological aspects that may be involved in this presentation of the disease are discussed., (© 2023 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
26. Major depression associated with a levonorgestrel-releasing intrauterine system mimicking frontotemporal dementia: a case report.
- Author
-
Valencia-Cifuentes V, Cañas CA, and Rivas JC
- Abstract
This case illustrates the adverse cognitive and affective effects associated with the use of an intrauterine hormonal contraceptive, which could be confused with symptoms of early onset dementia. We present a case of a 42-year-old woman diagnosed with seronegative spondyloarthropathy who subsequently developed anxiety and depressive symptoms after the implantation of a Levonorgestrel-Releasing Intrauterine System (LNG-IUS). Three years later, she began to experience memory and attentional failures, refractory pain, and severe depression. The progression of psychiatric symptoms led to a diagnosis of bipolar affective disorder and treatment with antidepressants and anxiolytics. Due to cognitive and psychiatric symptoms, autoimmune encephalitis was considered, but no improvement was shown with treatment. Early onset dementia was suspected, and a brain PET scan revealed frontal lobe hypometabolism. An adverse effect of LNG-IUS was considered; after its removal, mood and cognitive function improvements were observed. This case report emphasizes the importance of considering organic causes of unexplained psychiatric manifestations and highlights the potential impact of hormonal interventions on mental health., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Valencia-Cifuentes, Cañas and Rivas.)
- Published
- 2023
- Full Text
- View/download PDF
27. Systemic lupus erythematosus flare during SARS-CoV-2 infection: Report of 3 cases presented during the fourth wave of the pandemic in Colombia.
- Author
-
Naranjo-Millán JA, Bedoya-Joaqui V, and Cañas CA
- Subjects
- Humans, Pandemics, Colombia epidemiology, SARS-CoV-2, COVID-19 diagnosis, COVID-19 epidemiology, COVID-19 complications, Lupus Erythematosus, Systemic complications, Lupus Erythematosus, Systemic diagnosis, Lupus Erythematosus, Systemic drug therapy
- Abstract
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has become a worldwide pandemic since first discovered in 2019. Systemic lupus erythematosus (SLE) flare has been reported in the post-infectious period. In Colombia, the fourth pandemic wave started at the beginning of 2022 when we observed flare of 3 SLE patients during active infection., Case Presentation: We describe 3 patients with inactive SLE, who presented coronavirus disease 2019 and severe flare in early 2022, 2 patients with nephritis and 1 with severe thrombocytopenia. All patients had increase of antinuclear and anti-DNA antibody titers and complement consumption., Conclusions: Three cases with SLE flare concomitant with active SARS-CoV-2 infection were different from others reported earlier in the pandemic with post-infectious flare., (© 2023 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
28. Eosinophil-related diseases during treatment with glucagon-like peptide one receptor (GLP-1 RA): a case report and review of the literature.
- Author
-
Posso-Osorio I, Vargas-Potes CJ, Mejía M, and Cañas CA
- Subjects
- Female, Humans, Adult, Hypoglycemic Agents adverse effects, Glucagon-Like Peptide Receptors, Eosinophils, Glucagon-Like Peptide 1 therapeutic use, Diabetes Mellitus, Type 2 drug therapy
- Abstract
Glucagon-like peptide one-receptor agonists (GLP-1 RA) are drugs that differ in their pharmacological composition and homology to human GLP-1 and are used most frequently for the treatment of type 2 diabetes and weight loss. There are isolated reports of eosinophilic adverse reactions associated with GLP-1 RA. We present the case of a 42-year-old female patient who, after starting weekly subcutaneous semaglutide, developed eosinophilic fasciitis with favorable clinical evolution after the discontinuation of semaglutide and the initiation of immunosuppression. A review of the eosinophilic adverse events that have been previously reported with GLP-1 RA is provided., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
29. Diagnostic Performance of Anti-dsDNA Tests by Indirect Immunofluorescence and Enzyme-linked Immunosorbent Assay in Patients with Systemic Lupus Erythematosus.
- Author
-
Nieto-Aristizábal I, España LJ, Ortega J, Ruiz-Ordoñez I, Vivas ÁJ, Castaño GL, Castillo C, Bautista-Vargas M, Suárez A, Cañas CA, and Tobón GJ
- Subjects
- Humans, Enzyme-Linked Immunosorbent Assay standards, Fluorescent Antibody Technique, Indirect standards, Retrospective Studies, Male, Female, Young Adult, Adult, Middle Aged, Predictive Value of Tests, Regression Analysis, Lupus Erythematosus, Systemic diagnosis, Antibodies, Antinuclear analysis
- Abstract
Background: Several laboratory techniques for anti double-stranded (ds) DNA detection in systemic lupus erythematosus (SLE) are available, with variable diagnostic performance. We aimed to evaluate anti-dsDNA's diagnostic performance by indirect immunofluorescence (IIF) and enzyme-linked immunosorbent assay (EIA)., Methods: We conducted a single-center retrospective (2015 to 2020) study. Patients with anti-dsDNA tests by IIF and EIA were included. We evaluated the indications, applications, concordance, positive predictive value (PPV) of anti-dsDNA to confirm SLE diagnosis or flares, and associations of disease manifestations with positivity with each technique., Results: A total of 1368 reports of anti-dsDNA tests by IIF and EIA and the corresponding medical records of the patients were analyzed. The main indication for anti-dsDNA testing was to help in the diagnosis of SLE in 890 (65%) of the samples, and the main application after obtaining the results was SLE exclusion in 782 (57.2%) cases. The combination with the highest frequency was the negativity result by both techniques in 801 (58.5%) cases (Cohen kappa 0.57). Both methods were positive in 300 patients with SLE (Cohen kappa 0.42). The PPVs of anti-dsDNA tests to confirm diagnosis/flare was 79.64% (95% CI, 75.35-83.35) by EIA, 78.75% (95% CI, 74.27-82.62) by IIF, and 82% (95% CI, 77.26-85.93) when both were positive., Conclusions: Anti-dsDNA detection by IIF and EIA are complementary and may indicate different clinical patterns in patients with SLE. The detection of anti-dsDNA antibodies by both techniques has a higher PPV than either separately for confirming SLE diagnosis or flares. These results highlight the need for evaluating both methods in clinical practice., (© American Association for Clinical Chemistry 2023. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
30. The Colombian bushmasters Lachesis acrochorda (García, 1896) and Lachesis muta (Linnaeus, 1766): Snake species, venoms, envenomation, and its management.
- Author
-
Cañas CA, Castaño-Valencia S, and Castro-Herrera F
- Subjects
- Animals, Humans, Antivenins therapeutic use, Colombia, Viperidae, Crotalid Venoms
- Abstract
In Colombia, there are two species of bushmaster snakes, Lachesis acrochorda, which is distributed mainly in the west of the country (in the Choco region), and Lachesis muta in the southeast (in the Amazon and Orinoquia region), whose presence has been reduced due to the destruction of their habitats. Captive maintenance is challenging, making it difficult to obtain their venom for study and antivenom manufacturing. They are the largest vipers in the world. The occurrence of human envenomation is quite rare, but when it occurs, it is associated with high mortality. Bushmaster venom is necrotizing, hemorrhagic, myotoxic, hemolytic, and cardiovascular depressant. Due to the presence of bradycardia, hypotension, emesis, and diarrhea in some patients (Lachesis syndrome), the possibility of a vagal or cholinergic effect is raised. The treatment of envenomation is hindered by the scarcity of antivenom and the need to use high doses. A review of the most relevant biological and medical aspects of bushmaster snakes is presented, mainly for those occurring in Colombia, to facilitate their recognition and raise awareness about the need for special attention to improve their conservation and advance scientific knowledge, in particular, about their venom., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
31. Persistent and fatal severe acute respiratory syndrome coronavirus 2 infection in a patient with severe hypogammaglobulinemia: a case report.
- Author
-
Bedoya-Joaqui V, Gutiérrez-López MI, Caicedo PA, Villegas-Torres MF, Albornoz-Tovar LL, Vélez JD, Hidalgo-Cardona A, Tobón GJ, and Cañas CA
- Subjects
- Humans, Female, Middle Aged, Spike Glycoprotein, Coronavirus, SARS-CoV-2, Lung, COVID-19 complications, Agammaglobulinemia complications
- Abstract
Background: Viruses are constantly changing as a result of mutations, and new viral variants are expected to appear over time. The virus that causes coronavirus disease 2019, severe acute respiratory syndrome coronavirus 2, is not excluded from this condition. Patients with some types of immunodeficiency have been reported to experience symptoms that vary from mild to severe, or even death, after being infected with severe acute respiratory syndrome coronavirus 2. We report a case of a woman with severe hypogammaglobulinemia who developed a prolonged and fatal severe acute respiratory syndrome coronavirus 2 infection., Case Presentation: A 60-year-old mestizo female with a previous history of severe hypogammaglobulinemia manifested by recurrent pulmonary infections and follicular bronchiolitis. She received a monthly treatment of intravenous immunoglobulins and was admitted after report of a neurological manifestation related to a left thalamic inflammatory lesion, for a duration of 2 weeks of hospitalization, indicated for the study of her neurological condition, including brain biopsy. Both on admission and 1 week later, nasopharyngeal polymerase chain reaction tests for severe acute respiratory syndrome coronavirus 2 were performed and reported negative. In the third week of hospitalization, she developed pulmonary symptoms, and a positive test result for severe acute respiratory syndrome coronavirus 2 was evidenced. On Day 3, the patients' condition worsened as the infection progressed to respiratory failure and required mechanical ventilation. On Day 8 after the coronavirus disease 2019 diagnosis, the polymerase chain reaction test for severe acute respiratory syndrome coronavirus 2 showed persistent detection of the virus. Various bacterial coinfections, including Klebsiella pneumoniae and Enterobacter cloacae, were diagnosed and treated. On Day 35, her pulmonary symptoms worsened, and the results of the severe acute respiratory syndrome coronavirus 2 polymerase chain reaction test remained positive. On Day 36, despite all the respiratory support, the patient died. The severe acute respiratory syndrome coronavirus 2 virus was sequenced at the beginning and 8 days after the onset of the disease, and the strain, without obvious mutations in the gene that encodes spike protein, was identified., Conclusions: This clinical case showed persistent severe acute respiratory syndrome coronavirus 2 detection after 35 days of infection in a patient with severe hypogammaglobulinemia. The sequencing of the virus showed no mutations on the spike protein at 8 days, indicating that, in this case, the persistence of the viral detection was associated with immunodeficiency instead of changes in the viral components., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
32. Full Lockdowns Against the Pandemic: Time to Rethink the Paradigm.
- Author
-
Wilches Visbal JH, Castillo Pedraza MC, and Caballero Cañas CA
- Abstract
Competing Interests: There are no conflicts of interest.
- Published
- 2023
- Full Text
- View/download PDF
33. Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus.
- Author
-
Erazo-Martínez V, Tobón GJ, and Cañas CA
- Subjects
- Humans, Cytokines, Tumor Necrosis Factor-alpha, Ligands, Skin pathology, Chemokines metabolism, Immunologic Factors, Biopsy adverse effects, Inflammation, Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Systemic
- Abstract
Cutaneous lupus erythematosus (CLE) is a common disease that may appear as a separate entity from systemic lupus erythematosus (SLE), precede SLE development, or occur as a manifestation of this systemic disease. It has a complex pathophysiology that involves genetic, environmental, and immune-mediated factors creating a self-amplification pro-inflammatory cycle. CLE is characterized by prominent type I interferons (IFNs) inflammation which are considered as the first precursors of the inflammatory cascade generated within the pathophysiology of CLE. TNF-α enhances the production of antibodies through the activation of B cells, and favors the expression of surface nuclear antigens on keratinocytes. UV light exposure favors keratinocyte apoptosis or necroptosis, which results in the release of multiple proinflammatory cytokines, including IL-6, IL-1α, IL-1β, TNF-α, IFNs, and CXCL10. Serum levels of IL-17 are elevated in patients with ACLE, SCLE, and DLE. Evidence suggests IL-22 plays a role primarily in tissue repair rather than in inflammation. High expression of BAFF and its receptors have been found in lesioned keratinocytes of patients with CLE, and patients with CLE have lower serum levels of the regulatory cytokines TGF-β and IL-10. The chemokines CXCL9 and CXCL10 (CXCR3 ligands) have an increased expression among these patients, and their expression is correlated with IFNs levels. CXCR3 ligands recruit cytotoxic type I cells through this receptor, further supporting the death of keratinocytes via necroptosis with the subsequent release of eNAs perpetuating the inflammatory cycle. Interface dermatitis is characterized by the presence of CXCR3-positive lymphocytes. This review describes the leading cytokines and chemokines present in the circulation and skin that play a fundamental role in the pathogenesis of CLE., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
34. Lymphoid follicular hyperplasia in patients with systemic lupus erythematosus after multiple cycles of rituximab.
- Author
-
Ruiz-Ordóñez I, Santos VA, Bonilla-Abadía F, Silva N, Sánchez A, Tobón GJ, and Cañas CA
- Subjects
- Humans, Rituximab therapeutic use, B-Cell Activating Factor metabolism, B-Cell Activating Factor therapeutic use, Hyperplasia etiology, B-Cell Maturation Antigen therapeutic use, Lupus Erythematosus, Systemic complications, Lupus Erythematosus, Systemic diagnosis, Lupus Erythematosus, Systemic drug therapy, Lymphadenopathy
- Abstract
Rituximab is indicated in some patients with refractory systemic lupus erythematosus (SLE). Occasionally, this medication is required in chronic form to maintain control of the disease. We described two patients who developed lymphoid follicular hyperplasia (LFH) after multiple cycles of rituximab and evaluated the expression of B cell activating factor belonging to the tumor necrosis factor (TNF) family (BAFF) and its receptors [BAFF-receptor (BAFF-R) and B cell maturation antigen (BCMA)], as possible factors related to lymphoid node enlargement. Two patients with SLE completed six and nine cycles of rituximab (1 g every 2 weeks) indicated each 9 months, achieving remission for 5 and 7 years, respectively, when developed prominent lymphadenopathies. Biopsies showed LFH. Haematological neoplasms were ruled out. Immunohistochemistry showed BAFF overexpression in the follicles, and moderate expression of BAFF-R confined to the mantle zone and BCMA to the germinal centre. Belimumab B cell activating factor belonging to the TNF family (anti-BAFF therapy) was started with positive effects on the clinical condition. LFH can develop in patients with SLE who received multiple cycles of rituximab. BAFF overexpression and moderate expression of BAFF-R and BCMA in lymph nodes were seen. These findings added to the improvement with the change to belimumab could suggest that LFH after cluster of differentiation (CD20) depletion therapy may be associated with a compensatory overexpression of BAFF and its receptors., (© Japan College of Rheumatology 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
35. Biological and Medical Aspects Related to South American Rattlesnake Crotalus durissus (Linnaeus, 1758): A View from Colombia.
- Author
-
Cañas CA
- Subjects
- Animals, Humans, Colombia, Brazil, South American People, Crotalus metabolism, Crotalid Venoms toxicity, Crotalid Venoms metabolism
- Abstract
In Colombia, South America, there is a subspecies of the South American rattlesnake Crotalus durissus , C. d. cumanensis , a snake of the Viperidae family, whose presence has been reduced due to the destruction of its habitat. It is an enigmatic snake from the group of pit vipers, venomous, with large articulated front fangs, special designs on its body, and a characteristic rattle on its tail. Unlike in Brazil, the occurrence of human envenomation by C. durisus in Colombia is very rare and contributes to less than 1% of envenomation caused by snakes. Its venom is a complex cocktail of proteins with different biological effects, which evolved with the purpose of paralyzing the prey, killing it, and starting its digestive process, as well as having defense functions. When its venom is injected into humans as the result of a bite, the victim presents with both local tissue damage and with systemic involvement, including a diverse degree of neurotoxic, myotoxic, nephrotoxic, and coagulopathic effects, among others. Its biological effects are being studied for use in human health, including the possible development of analgesic, muscle relaxant, anti-inflammatory, immunosuppressive, anti-infection, and antineoplastic drugs. Several groups of researchers in Brazil are very active in their contributions in this regard. In this work, a review is made of the most relevant biological and medical aspects related to the South American rattlesnake and of what may be of importance for a better understanding of the snake C. d. cumanensis , present in Colombia and Venezuela.
- Published
- 2022
- Full Text
- View/download PDF
36. Rheumatological diseases in patients with primary hyperparathyroidism.
- Author
-
Erazo-Martínez V, Alejandro-Posso J, Medellín C, Kaimoto M, Cañas CA, and Tobón GJ
- Subjects
- Humans, Hyperparathyroidism, Primary complications, Arthritis, Rheumatoid, Lupus Erythematosus, Systemic, Autoimmune Diseases
- Published
- 2022
- Full Text
- View/download PDF
37. Improvement of the autoimmune phenomenon after treatment of primary hyperparathyroidism: Possible role of dynamics of parathyroid hormone-1-receptor in B-lymphocytes.
- Author
-
Posso-Osorio I, Rios-Serna LJ, Rosero AM, Cárdenas D, Tobón GJ, and Cañas CA
- Abstract
We report a case of 65-year-old male patient with primary hyperparathyroidism (PHPT) who was admitted to the hospital for autoimmune manifestations (including autoimmune hepatitis and autoantibody development) and exhibited subsequent clinical and paraclinical improvement after parathyroidectomy. By flow cytometry, the expression of PTH receptor 1 (PTHR1) on B lymphocytes of peripheral blood was documented to be higher than that in healthy controls. After parathyroidectomy, autoimmune manifestations improved, while PTH1R expression on B-lymphocytes increased. The possible role of the dynamics of B-lymphocyte PTHR1 in the development of this autoimmune phenomenon is discussed., Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Gabriel J. Tobon reports financial support was provided by Colombia Ministry of Science Technology and Innovation., (© 2022 Published by Elsevier B.V.)
- Published
- 2022
- Full Text
- View/download PDF
38. Biological and medical aspects related to the yellow-bellied sea snake Hydrophis platurus (Linnaeus, 1766): A view from Colombia.
- Author
-
Cañas CA, Castaño-Valencia S, and Castro-Herrera F
- Subjects
- Animals, Colombia, Elapidae, Humans, Hydrophiidae, Snake Bites
- Abstract
In Colombia, 317 species of snakes have been recognized, of which 51 (17%) have medical importance due to the toxicity of their venom. A total of 95% of envenomations are caused by snakes of the family Viperidae and 5% of the family Elapidae. The latter form of envenomation is mainly caused by snakes of the genus Micrurus. The only sea snake described is the yellow-bellied snake (Hydrophis platurus), present in the Pacific Ocean. Although Colombia has approximately 1300 km on the Pacific coast and a significant presence of H platurus, envenomation is rare. As a result of the care of a patient with this type of envenomation and of the donation of a H platurus specimen to our laboratory, we decided to conduct this review on the most relevant biological, epidemiological and clinical aspects of this enigmatic and interesting species., Competing Interests: Declaration of competing interest The authors declare that they have no competing interests., (Copyright © 2022 Elsevier Ltd. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
39. An idiotypic network dysregulation could be related to the pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT) following vaccination with vaccines expressing Spike protein of SARS CoV2.
- Author
-
Cañas CA, Posso-Osorio I, Bedoya-Joaqui V, López HE, and Tobón GJ
- Subjects
- Humans, Spike Glycoprotein, Coronavirus, Vaccination adverse effects, COVID-19, Purpura, Thrombocytopenic, Idiopathic, Severe Acute Respiratory Syndrome complications, Thrombocytopenia etiology, Vaccines adverse effects
- Published
- 2022
- Full Text
- View/download PDF
40. Biological Effects of Animal Venoms on the Human Immune System.
- Author
-
Avalo Z, Barrera MC, Agudelo-Delgado M, Tobón GJ, and Cañas CA
- Subjects
- Animals, Digestion, Humans, Immune System, Venoms, Autoimmune Diseases, Body Fluids
- Abstract
Venoms are products of specialized glands and serve many living organisms to immobilize and kill prey, start digestive processes and act as a defense mechanism. Venoms affect different cells, cellular structures and tissues, such as skin, nervous, hematological, digestive, excretory and immune systems, as well as the heart, among other structures. Components of both the innate and adaptive immune systems can be stimulated or suppressed. Studying the effects on the cells and molecules produced by the immune system has been useful in many biomedical fields. The effects of venoms can be the basis for research and development of therapeutic protocols useful in the modulation of the immunological system, including different autoimmune diseases. This review focuses on the understanding of biological effects of diverse venom on the human immune system and how some of their components can be useful for the study and development of immunomodulatory drugs.
- Published
- 2022
- Full Text
- View/download PDF
41. Atypical Hemolytic Uremic Syndrome in a Patient With Bothrops asper Envenomation.
- Author
-
Cañas CA, Vecino MJ, and Posso-Osorio I
- Subjects
- Animals, Antivenins therapeutic use, Female, Humans, Male, Venoms therapeutic use, Atypical Hemolytic Uremic Syndrome complications, Atypical Hemolytic Uremic Syndrome drug therapy, Blood Coagulation Disorders etiology, Blood Coagulation Disorders therapy, Bothrops, Disseminated Intravascular Coagulation etiology, Disseminated Intravascular Coagulation therapy, Snake Bites complications, Snake Bites therapy, Thrombotic Microangiopathies etiology
- Abstract
Bothrops asper envenomation is common in Colombia and is characterized by local tissue injury and venom-induced consumption coagulopathy (VICC). Rarely, thrombotic microangiopathy is associated with envenomation by this species. The case of a 57-y-old man with B asper bite and envenomation on the left foot is presented. The patient was admitted 8 h after the event and progressively developed edema, hemorrhage at the site of the bite, and hemorrhagic blisters. His coagulation test results (prothrombin and partial thromboplastin times) were prolonged, and his fibrinogen levels were severely reduced. The diagnosis of VICC was made. Administration of Colombian polyvalent viper antivenom controlled the VICC within a few hours. Subsequently, the patient developed severe microangiopathic anemia, thrombocytopenia, and acute kidney injury. A diagnosis of thrombotic microangiopathy was made, and the patient met the criteria for hemolytic uremic syndrome. Management with hemodialysis in addition to therapeutic plasma exchange and replacement with fresh frozen plasma was indicated. The patient's condition resolved 14 d later. To the best of our knowledge, this is the first case of B asper envenomation in which the patient presented with hemolytic uremic syndrome after VICC. A proposal is made regarding the pathogenesis of this chain of events., (Copyright © 2021 Wilderness Medical Society. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
42. Clinical Characteristics and Outcomes of Patients With ANCA-Associated Vasculitides in a Colombian Hospital.
- Author
-
Santacruz-Sandoval E, López-Bonilla J, Guevara-Calderón LA, Nieto-Aristizábal I, Ruiz-Ordoñez I, Cañas CA, Santos VA, Tobón GJ, and Aguirre-Valencia D
- Subjects
- Antibodies, Antineutrophil Cytoplasmic, Colombia epidemiology, Female, Hospitals, Humans, Male, Middle Aged, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis diagnosis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis epidemiology, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis therapy, Granulomatosis with Polyangiitis diagnosis, Granulomatosis with Polyangiitis epidemiology, Granulomatosis with Polyangiitis therapy, Microscopic Polyangiitis diagnosis, Microscopic Polyangiitis epidemiology, Microscopic Polyangiitis therapy
- Abstract
Background/objective: Antineutrophil cytoplasmic antibody-associated vasculitides (AAVs) are uncommon systemic autoimmune diseases, of which few reports exist in Latin America. Our aim was to examine AAV evaluated in a high-complexity hospital in southwestern Colombia, with emphasis in severe forms., Methods: A medical records review study of 67 patients was performed, and data were collected from electronic registries. Moderate and severe AAVs were defined as the presence of life-threatening complications, unfavorable Birmingham Vasculitis Activity Score outcomes, and hospitalization requirements at the time of diagnosis and by the last follow-up, between 2011 and 2019. Clinical manifestations, treatment, and outcomes were evaluated. The AAV subtypes were compared., Results: A total of 67 cases were included. The majority were female (n = 44, 65.67%), and the median age was 52 (40-64) years. Granulomatosis with polyangiitis (GPA) was the most frequent with 42 patients (62.68%), followed by microscopic polyangiitis (MPA) and eosinophilic GPA, with 15 patients (22.38%) and 10 patients (14.92%), respectively. Forty-four patients (65.67%) presented pulmonary symptoms. The highest Birmingham Vasculitis Activity Score corresponded to MPA, with 21 (12-25) points. Fifteen patients (22.4%) were admitted to the intensive care unit throughout the course of the disease, of whom 10 had GPA. The longest stay and duration of mechanical ventilation were seen in MPA. The principal treatments were corticosteroids and cyclophosphamide, and the main outcome was end-stage renal disease., Conclusions: In this cohort of AAV, most of cases corresponded to GPA, and pulmonary manifestations were the most common. Microscopic polyangiitis was the more severe subtype as it showed worse impairment in clinical characteristics and intensive care unit requirements., Competing Interests: The authors declare no conflict of interest., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
43. Pharmacological blockade of KV1.3 channel as a promising treatment in autoimmune diseases.
- Author
-
Cañas CA, Castaño-Valencia S, and Castro-Herrera F
- Abstract
There are more than 100 autoimmune diseases (AD), which have a high prevalence that ranges between 5% and 8% of the general population. Type I diabetes mellitus, multiple sclerosis, systemic lupus erythematosus and rheumatoid arthritis remain the health problem of highest concern among people worldwide due to its high morbidity and mortality. The development of new treatment strategies has become a research hotspot. In recent years, the study of the ion channels presents in the cells of the immune system, regarding their functional role, the consequences of mutations in their genes and the different ways of blocking them are the subject of intense research. Pharmacological blockade of KV1.3 channel inhibits Ca2+ signaling, T cell proliferation, and pro-inflammatory interleukins production in human CD4
+ effector memory T cells. These cells mediated most of the AD and their inhibition is a promising therapeutic target. In this review, we will highlight the biological function of KV1.3 channel in T cells, consequence of the pharmacological inhibition (through anemone and scorpion toxins, synthetic peptides, nanoparticles, or monoclonal antibodies) as well as the possible therapeutical application in AD., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2022 The Authors. Published by Elsevier B.V.)- Published
- 2022
- Full Text
- View/download PDF
44. Human endogenous retroviruses (HERV) and non-HERV viruses incorporated into the human genome and their role in the development of autoimmune diseases.
- Author
-
Posso-Osorio I, Tobón GJ, and Cañas CA
- Abstract
Genomic incorporation of viruses as human endogenous retroviruses (HERVs) are components of our genome that possibly originated by incorporating ancestral of exogenous viruses. Their roles in the evolution of the human genome, gene expression, and the pathogenesis of autoimmune diseases (ADs) and neoplastic phenomena are the subject of intense research. This review analyzes the evolutionary and virological aspects of HERVs and other viruses that incorporate their genome into the human genome and have known role in the genesis of ADs. These insights are helpful to understand further the possible role in autoimmunity genesis of HERVs, other ancestral viruses no HERVs and modern viruses with the ability to incorporate into the human genome or interact with HERVs., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2021 Published by Elsevier B.V.)
- Published
- 2021
- Full Text
- View/download PDF
45. Expression of parathormone receptor on B-lymphocytes in systemic lupus erythematosus and Sjögren's syndrome.
- Author
-
Rios-Serna LJ, Nieto-Aristizábal I, Ruiz-Ordoñez I, Mendez-Rayo T, Posso-Osorio I, García J, Navarro EP, Barrera MC, Aguirre-Valencia D, Cañas CA, and Tobón GJ
- Subjects
- Adult, Biomarkers metabolism, Female, Humans, Male, B-Lymphocytes metabolism, Lupus Erythematosus, Systemic metabolism, Receptor, Parathyroid Hormone, Type 1 biosynthesis, Sjogren's Syndrome metabolism
- Published
- 2021
- Full Text
- View/download PDF
46. Polymyalgia rheumatica: A case series from Colombia and analysis of Latin America.
- Author
-
Toro-Gutiérrez CE, Cañas CA, Mantilla RD, Beltrán S, Pastrana-Gonzalez V, Vecino MJ, Rodriguez-Jimenez M, and Rojas M
- Abstract
Objective: Polymyalgia rheumatica (PMR) is the most common inflammatory disease in patients over 50 years. Information about the disease in Latin America (LATAM) is scarce. We aimed to evaluate a group of Colombian patients with PMR and to conduct a systematic review of PMR in LATAM., Methods: A multicentric retrospective study was performed. Medical records of 256 PMR patients were evaluated. Patients were divided into two groups, those fulfilling the 2012 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria for PMR and those who did not (i.e., clinical diagnosis). A systematic literature review and meta regression was performed comparing Colombian vs LATAM patients., Results: From 256 patients, 145 (56.6%) fulfilled the 2012 EULAR/ACR criteria, and 111 (43.3%) were classified by clinical diagnosis. Inflammatory bilateral shoulder pain, pelvic girdle aching, morning stiffness >45 min, elevated erythrocyte sedimentation rate (ESR), and C-reactive protein (CPR), and Methotrexate (MTX) prescription were more common in the 2012 EULAR/ACR group. None of the included patients presented overt polyautoimmunity (PolyA), whereas up to 24% exhibited latent PolyA. In addition, these patients showed high frequency of malignancy (7.59%). In the meta regression analysis, Colombian patients exhibited lower ESR levels, and were less likely to develop giant cell arteritis (GCA) as compared to the rest of LATAM data., Conclusion: Patients with PMR in LATAM exhibit similar phenotypes from other cohorts worldwide. Malignancy, GCA and latent PolyA should be considered in the routine clinical follow-up of patients with PMR., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2021 The Authors. Published by Elsevier B.V.)
- Published
- 2021
- Full Text
- View/download PDF
47. Validation and adaptation to Spanish of the EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI).
- Author
-
Posso-Osorio I, Nieto-Aristizábal I, Soto D, Ariza C, Urbano M, Cañas CA, Echeverri A, Castillo A, and Tobón GJ
- Subjects
- Cross-Sectional Studies, Female, Humans, Language, Patient Reported Outcome Measures, Quality of Life, Reproducibility of Results, Severity of Illness Index, Sjogren's Syndrome diagnosis
- Abstract
Introduction and Objectives: Sjögren's Syndrome (SS) is an autoimmune disease with a wide spectrum of clinical manifestations that can have an important impact on the patient's quality of life. To make an objective evaluation of the components of the disease, clinimetric tools such as the ESSPRI have been designed. The objective of this study is to adapt this scale to the Spanish language., Materials and Methods: This is a cross-sectional study to validate clinimetric scales, carried out in Cali, Colombia. A translation of the original English version of ESSPRI into Spanish was made and applied to patients with SS, as well as PROFAD and ESSDAI, as an activity marker. The reliability index of the questionnaire in Spanish with Cronbach's alpha coefficient and Spearman's correlation coefficient were calculated to compare the scales. Demographic, clinical and laboratory characteristics were also evaluated., Results: ESSPRI, PROFAD and ESSDAI were applied to 42 patients with SS, 97.62% were women. The average result of the ESSPRI was 5.8 (± 4.6), with a reliability coefficient of .8034 and a correlation with PROFAD of .5800 (p=.0001), and of -.0848 (p=.593) with ESSDAI., Discussion and Conclusions: Reliability with the applied version of ESSPRI in Spanish was adequate. A discrepancy was found between this scale and ESSDAI, which highlights the importance of applying both tools to ensure objective monitoring of disease control and its impact on the quality of life of patients with SS., (Copyright © 2020 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
48. Very Severe and Refractory Noninfectious Cystitis in Patients with Systemic Lupus Erythematosus: Potential Role of Rituximab Therapy.
- Author
-
Ocampo-Piraquive V, Mondragón-Lenis I, De Los Rios JG, and Cañas CA
- Abstract
Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease with various clinical manifestations, including, rarely, a form of interstitial cystitis (lupus cystitis, LC). LC can be asymptomatic and usually has discrete symptoms that improve with conventional therapies available for SLE and/or typical interstitial cystitis. A very severe and refractory form is rarely described. In this study, we present four patients with SLE and a very severe form of noninfectious cystitis refractory to the different forms of treatment described. The clinical descriptions of the cases, demographic factors, manifestations associated with SLE, and clinical and paraclinical manifestations related to cystitis, treatments, and outcomes are provided. A proposal for the pathogenesis of this condition is based on the common findings of these patients, including the fact that three were in SLE remission and all four receiving rituximab as induction and/or maintenance therapy., Competing Interests: The authors declare that they have no conflicts of interest., (Copyright © 2021 Vanessa Ocampo-Piraquive et al.)
- Published
- 2021
- Full Text
- View/download PDF
49. Clinical syndromes associated with Viperidae family snake envenomation in southwestern Colombia.
- Author
-
Cañas CA, Castro-Herrera F, and Castaño-Valencia S
- Subjects
- Adult, Animals, Antivenins therapeutic use, Colombia epidemiology, Humans, Male, Prospective Studies, Syndrome, Bothrops, Snake Bites epidemiology, Viperidae
- Abstract
Background: In southwestern Colombia there is a notable variety of snakes that belong to the Viperidae family (vipers). The particular clinical manifestation related to species is poorly reported., Methods: Based on a prospective study about envenomation caused by vipers from 2011 to 2019 at the Fundación Valle del Lili Hospital, Cali, in southwest Colombia, we selected cases of admitted patients in which the snakes responsible were fully identified. They were cataloged by clinical syndrome according to prevalent signs (edema-inducing, necrotizing, blister-inducing, procoagulant, anticoagulant or myotoxic) and were related to the species that caused the envenomation., Results: From a cohort of 53 patients, 21 patients (16 males [72.7%]) with an average age of 35 (3-69) y were included. The syndromes associated with envenomation were anticoagulant and necrotizing effects of Bothrops asper (five patients [22.7%]), blister-inducing and anticoagulant effects of Bothrops rhombeatus (five [22.7%]), anticoagulant effects of Bothrops punctatus (three patients [13.6%]), edema-inducing and anticoagulant effects of Bothriechis schlegelii (five [22.7%]), edema-inducing and myotoxic effects of Bothrocophias colombianus (one [4.5%]), edema-inducing and myotoxic effects of Bothrocophias myersi (one [4.5%]) and edema-inducing effects of Porthidium nasutum (one [4.5%])., Conclusion: In southwestern Colombia there is notable variety in species of snakes belonging to the family Viperidae (vipers) whose envenomation causes various clinical syndromes., (© The Author(s) 2020. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.)
- Published
- 2021
- Full Text
- View/download PDF
50. Role of Tissue Factor in the Pathogenesis of COVID-19 and the Possible Ways to Inhibit It.
- Author
-
Cañas CA, Cañas F, Bautista-Vargas M, and Bonilla-Abadía F
- Subjects
- Angiotensin-Converting Enzyme 2 metabolism, COVID-19 epidemiology, Cytokines metabolism, Humans, COVID-19 metabolism, Celecoxib therapeutic use, Colchicine therapeutic use, Cyclosporine therapeutic use, SARS-CoV-2 metabolism, Thromboplastin metabolism, COVID-19 Drug Treatment
- Abstract
COVID-19 (Coronavirus Disease 2019) is a highly contagious infection and associated with high mortality rates, primarily in elderly; patients with heart failure; high blood pressure; diabetes mellitus; and those who are smokers. These conditions are associated to increase in the level of the pulmonary epithelium expression of angiotensin-converting enzyme 2 (ACE-2), which is a recognized receptor of the S protein of the causative agent SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). Severe cases are manifested by parenchymal lung involvement with a significant inflammatory response and the development of microvascular thrombosis. Several factors have been involved in developing this prothrombotic state, including the inflammatory reaction itself with the participation of proinflammatory cytokines, endothelial dysfunction/endotheliitis, the presence of antiphospholipid antibodies, and possibly the tissue factor (TF) overexpression. ARS-Cov-19 ACE-2 down-regulation has been associated with an increase in angiotensin 2 (AT2). The action of proinflammatory cytokines, the increase in AT2 and the presence of antiphospholipid antibodies are known factors for TF activation and overexpression. It is very likely that the overexpression of TF in COVID-19 may be related to the pathogenesis of the disease, hence the importance of knowing the aspects related to this protein and the therapeutic strategies that can be derived. Different therapeutic strategies are being built to curb the expression of TF as a therapeutic target for various prothrombotic events; therefore, analyzing this treatment strategy for COVID-19-associated coagulopathy is rational. Medications such as celecoxib, cyclosporine or colchicine can impact on COVID-19, in addition to its anti-inflammatory effect, through inhibition of TF.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.